ALFA Finder| Revenue growth | Q2 revenue +37% YoY; H1 +38%; volume-led, not one-time. |
|---|---|
| Margins | Network EBITDA 26% Q2; Sayadri up from 15.5% FY26 to 19.5%. |
| Demand visibility | October started well; eastern government-scheme demand uncertain. |
| Management confidence | Over-optimistic: 'best ever quarter'; defers hard guidance. |
Growth
Volume-led: inpatient volumes +35%, outpatient +27% YoY, occupancy 70%. Sayadri Q2 revenue ₹375 Cr, +13% QoQ.
Outlook
No revenue or EBITDA guidance; Sayadri margin target 23-24% within 4-5 years of acquisition.
Risks
Eastern government-scheme volumes down 17% (H1); Electronic City ₹13 Cr EBITDA loss; no EBITDA guidance given.
Last quarter's promises, checked
Delivered
- Guided Q2 debt repayment (2.8x→0.9x) → repaid 15 Sept (= BEAT)
- Guided ~300-bed Electronic City in Q2 → launched July as 50th hospital (= BEAT)
- Guided Kinder transfer ~60 days post-CPs → completed in Q2 (= BEAT)
Partly delivered
- Guided FY27 capex ~INR2,000 Cr (INR900 Cr in Q1) → Q2 capex not disclosed (= PARTIAL)
Missed
- Guided govt business 'pretty flat', scheme fix 'very shortly' → Eastern govt volumes -17% H1, transition ongoing (= MISS)
Earnings Call Transcript filed with NSE, NSE: MANIPALHOS. Summary written with AI assistance from the document.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹677.05
- Market cap
- ₹89,058 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Other Announcement
Manipal Health Enterprises submitted CARE Ratings' monitoring agency report for the quarter ended September 30, 2026. It reports nil deviation from the IPO objects.
Manipal Health Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹3,399 Cr (+37.3%), EBITDA ₹882 Cr (+29.8%), margin 26.0%, PAT ex-exceptions ₹380 Cr (+21.6%). Growth is volume-led, helped by Sahyadri consolidation.
Manipal Health Enterprises Q2 FY27 Results: Net Profit ₹285 Cr, Down 10.3% YoY
Manipal Health Enterprises Ltd reported revenue from operations of ₹3,399 Cr (+37.3% YoY) and net profit of ₹285 Cr (-10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹285 Cr · -10.3% YoY
Manipal Health Enterprises Capacity Expansion
Manipal Health Enterprises executed a 29-year-11-month land lease with TIL Investments to build and operate a hospital in Gurugram. No monetary value is disclosed.
- Execution
- 29 years 11 months
Manipal Health Enterprises Board Meeting Date
Manipal Health Enterprises gave notice that its board meets on 13 November 2026 to approve the Q2 and H1 FY27 standalone and consolidated unaudited results. This is advance intimation, and the agenda is proposed only.
Manipal Health Enterprises Legal & Regulatory
Manipal Health's subsidiary received two GST orders imposing penalties totalling about Rs 4.61 Crore. The company says the orders are appealable and the impact is not material.
- Value
- ₹4.61 Cr